Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bryan T. Baldasare currently holds 975 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bryan T. Baldasare has been a net seller of INM stock. They have purchased $13.9K and sold $566.8K worth of shares.
Bryan T. Baldasare's most recent insider trade was on Dec 20, 2024, when they sold 550 shares at $0.00 per share.
Bryan T. Baldasare serves as Executive at InMed Pharmaceuticals Inc. (INM). They have executed 19 insider transactions totaling $580.8K over their tenure at the company.
Bryan T. Baldasare holds the position of Executive at InMed Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Bryan T. Baldasare has shown a selling trading pattern, with $13.9K in total purchases and $566.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bryan T. Baldasare was on Feb 5, 2021, when they sold $379.2K worth of VIVO shares. This transaction involved 14,250 shares at $26.61 per share.
Bryan T. Baldasare currently owns 975 shares of InMed Pharmaceuticals Inc. (INM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bryan T. Baldasare's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bryan T. Baldasare has 19 Form 4 filings on record as an insider at InMed Pharmaceuticals Inc..
Set alerts for Bryan T. Baldasare and 40,000+ other insiders.